- Home
- LTRN vs DTIL Comparison
LTRN vs DTIL Comparison
Compare LTRN & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTRN
- DTIL
- Stock Information
- Founded
- LTRN 2013
- DTIL 2006
- Country
- LTRN United States
- DTIL United States
- Employees
- LTRN N/A
- DTIL N/A
- Industry
- LTRN Biotechnology: Pharmaceutical Preparations
- DTIL Biotechnology: Pharmaceutical Preparations
- Sector
- LTRN Health Care
- DTIL Health Care
- Exchange
- LTRN Nasdaq
- DTIL Nasdaq
- Market Cap
- LTRN 46.7M
- DTIL 43.3M
- IPO Year
- LTRN 2020
- DTIL 2019
- Fundamental
- Price
- LTRN $3.54
- DTIL $4.69
- Analyst Decision
- LTRN Hold
- DTIL Strong Buy
- Analyst Count
- LTRN 1
- DTIL 3
- Target Price
- LTRN N/A
- DTIL $37.67
- AVG Volume (30 Days)
- LTRN 27.6K
- DTIL 134.3K
- Earning Date
- LTRN 03-27-2025
- DTIL 03-26-2025
- Dividend Yield
- LTRN N/A
- DTIL N/A
- EPS Growth
- LTRN N/A
- DTIL N/A
- EPS
- LTRN N/A
- DTIL 1.04
- Revenue
- LTRN N/A
- DTIL $68,696,000.00
- Revenue This Year
- LTRN N/A
- DTIL N/A
- Revenue Next Year
- LTRN N/A
- DTIL $58.46
- P/E Ratio
- LTRN N/A
- DTIL $4.59
- Revenue Growth
- LTRN N/A
- DTIL 40.98
- 52 Week Low
- LTRN $2.79
- DTIL $3.61
- 52 Week High
- LTRN $9.96
- DTIL $15.97
- Technical
- Relative Strength Index (RSI)
- LTRN 39.55
- DTIL 39.70
- Support Level
- LTRN $3.62
- DTIL $4.30
- Resistance Level
- LTRN $4.00
- DTIL $5.72
- Average True Range (ATR)
- LTRN 0.24
- DTIL 0.34
- MACD
- LTRN -0.00
- DTIL -0.07
- Stochastic Oscillator
- LTRN 22.93
- DTIL 23.81
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.